Sanye Tablets

1. To explore the optimal therapeutic dose of Sanyeban for people with type 2 diabetes (phlegm turbidity and blood stasis syndrome) who have not met the target group on metformin monotherapy; 2. To explore the optimal therapeutic dose of Sanyeban for people with type 2 diabetes (phlegm turbidity and blood stasis syndrome) who have just been treated; 3. To compare the efficacy of Sanyeban in people with type 2 diabetes (phlegm turbidity and blood stasis syndrome) who have not met the target group on metformin monotherapy; 4. To observe the safety of Sanyeban in clinical application.